Manning & Napier Group's SUPN Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 38 shares of Supernus Pharmaceuticals, Inc. (SUPN) worth $1,778, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Manning & Napier Group has initiated a new position in SUPN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Supernus Pharmaceuticals (SUPN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Supernus Pharmaceuticals (SUPN) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +38 | New Buy | 38 | $46.79 |
Manning & Napier Group's Supernus Pharmaceuticals Investment FAQs
Manning & Napier Group first purchased Supernus Pharmaceuticals, Inc. (SUPN) in Q2 2026, acquiring 38 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Supernus Pharmaceuticals, Inc. (SUPN) for 1 quarters since Q2 2026.
Manning & Napier Group's largest addition to Supernus Pharmaceuticals, Inc. (SUPN) was in Q2 2026, adding 38 shares worth $1,778.
According to the latest 13F filing for Q2 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 38 shares of Supernus Pharmaceuticals, Inc. (SUPN), valued at approximately $1,778.
As of the Q2 2026 filing, Supernus Pharmaceuticals, Inc. (SUPN) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Supernus Pharmaceuticals, Inc. (SUPN) was 38 shares, as reported at the end of Q2 2026.